Key result
Mechanical circulatory support is linked to 75% hospital survival in fulminant myocarditis with cardiogenic shock.
Why the study?
Patients with fulminant myocarditis complicated by cardiogenic shock refractory to medical treatment may benefit from mechanical circulatory support, but data on outcomes are limited.
Does short-term mechanical circulatory support improve hospital survival in patients with fulminant myocarditis complicated by cardiogenic shock?
Observational (n=4)
No
Does short-term mechanical circulatory support improve hospital survival in patients with fulminant myocarditis complicated by cardiogenic shock?
Short-term mechanical circulatory support can provide an effective bridge to recovery with high survival rates in patients with fulminant myocarditis complicated by cardiogenic shock.
No takes yet. Share an insight, caveat, or question.
May support MCS in refractory fulminant myocarditis shock; leaves open need for prospective validation in larger cohorts.
Jankuvienė et al. (2021) conducted an observational in Fulminant myocarditis related cardiogenic shock (n=4). Mechanical circulatory support (ECMO or ventricular assist devices) was evaluated on Hospital survival. Mechanical circulatory support resulted in a 75% hospital survival rate in patients with fulminant myocarditis complicated by cardiogenic shock.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: